𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopaminergic inhibition of growth hormone and prolactinn release during continuous in vitro perifusion of normal and adenomatous human pituitary

✍ Scribed by N.F. Lawton; A.J. Evans; R.O. Weller


Book ID
118929374
Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
730 KB
Volume
49
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Lack of effect of interleukins 1Ξ± and 1Ξ²
✍ S. MΓ©lik Parsadaniantz; V. Lenoir; B. Terlain; B. KerdelhuΓ© πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 803 KB

It has been demonstrated that interleukin 1 (ILl) injection provokes a great variety of biological effects, notably an activation of the corticotropic axis, increasing plasma adrenocorticotropic hormone (ACTH) and corticosterone. However, the primary site of action of IL1 is still controversial. In

Inhibition of proliferation in human MNN
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 331 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc